CIK 0001137883 · Non-accelerated filer<br>Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 207273918
- Phone
- 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-01 | Taylor Kirk Chief Medical Officer | Grant or award | +35,000 | 35,000 | ||
| 2023-05-01 | Taylor Kirk Chief Medical Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2023-04-20 | Lebovits Chaim President & Co-CEO | Grant or award | +75,000 | 262,110 | ||
| 2023-04-20 | Lindborg Stacy Co-Chief Executive Officer | Grant or award | +75,000 | 135,000 | ||
| 2022-12-07 | Lindborg Stacy Co-Chief Executive Officer | Grant or award | +35,000 | 60,000 | ||
| 2022-09-18 | Lebovits Chaim Chief Executive Officer | Grant or award | +31,185 | 187,110 | ||
| 2022-04-06 | FRENKEL JACOB A Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-03-06 | Kern Ralph Dr. COO and Chief Medical Officer | Grant or award | +35,885 | 223,310 | ||
| 2022-02-01 | Polverino Anthony J. Director | Grant or award | +3,882 | 25,960 | ||
| 2021-12-15 | TAUB MALCOLM S Director | Grant or award | +12,000 | 77,332 | ||
| 2021-12-15 | Polverino Anthony J. Director | Grant or award | +2,000 | 22,078 | ||
| 2021-12-15 | Almenoff June Sherie Director | Grant or award | +2,000 | 6,000 | ||
| 2021-12-15 | Yablonka Uri Director | Grant or award · Stock Option (right to buy) | +13,333 | 13,333 | ||
| 2021-12-15 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2021-12-10 | Kern Ralph Dr. COO and Chief Medical Officer | Grant or award | +35,885 | 187,425 | ||
| 2021-12-10 | Lebovits Chaim Chief Executive Officer | Grant or award | +31,185 | 155,925 | ||
| 2021-12-10 | TAUB MALCOLM S Director | Grant or award | +12,000 | 65,332 | ||
| 2021-12-10 | Polverino Anthony J. Director | Grant or award | +2,216 | 18,078 | ||
| 2021-12-10 | Polverino Anthony J. Director | Grant or award | +2,000 | 20,078 | ||
| 2021-12-10 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 |
Page 4 of 7 · 127 trades